Age (mean±SD) |
64±9.4 |
Gender (Male/female) |
16/2 |
Histopathology
SCLC2
NSCLC3
Adenocarcinoma
Squamous cell carcinoma
|
5 (27.8%)
13 (72.2%)
5 (27.8%)
8 (44.4%)
|
TNM Stage
Stage I-II
Stage III
Stage IV
|
2 (11.1%)
6 (33.3%)
10 (55.6%)
|
Therapy
Chemotherapy
Palliative radiotherapy
Immunothetapy
Best supportive care
Chemo-radiotherapy
Treatment completed
|
9 (50%)
1 (5.6%)
1 (5.6%)
3 (16.7%)
2 (11.1%)
2 (11.1%)
|
Symptom
Fever
Shortness of breath
Sputum purulence
Cough
Myalgia
|
10 (55.6%)
14 (77.8%)
5 (31.2%)
5 (31.2%)
3 (18.7%)
|
Pathology on X-ray |
14 (77.8%) |
Hypoxia |
11 (61.1.%) |
Lymphopenia |
12 (75%) |
Elevated lactate dehydrogenase |
12 (75%) |
Tomography findings
Consolidation
Ground glass opacities
Thoracic mass/Lymphadenopathy
Pleural efussion
|
8 (44.4%)
8 (44.4%)
3 (16.7%)
5 (27.8%)
|